Clinical Trial Search block Test
A Phase 3, Prospective, Open-Label, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Paricalcitol Oral Solution for the Treatment of Secondary Hyperparathyroidism in Pediatric Subjects Ages 0 to 9 Years with Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Abbvie_Zemplar
What is the goal of the study?
To learn more about this study, please email the study team member listed below.
Who can participate in the study?
Everyone